1. Hishikawa, T, Sugiu, K, Date, I. Moyamoya disease: A review of clinical research. Acta Med Okayama 2016; 70: 229–236.
Google Scholar | Medline2. Suzuki, J, Takaku, A. Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969; 20: 288–299.
Google Scholar | Crossref | Medline3. Scott, RM, Smith, ER. Moyamoya disease and moyamoya syndrome. N Engl J Med 2009; 360: 1226–1237.
Google Scholar | Crossref | Medline | ISI4. Uchino, K, Johnston, SC, Becker, KJ, et al. Moyamoya disease in Washington State and California. Neurology 2005; 65: 956–958.
Google Scholar | Crossref | Medline | ISI5. Fukui, M, Kono, S, Sueishi, K, et al. Moyamoya disease. Neuropathology 2000; 20: S61–S64.
Google Scholar | Crossref | Medline | ISI6. Berry, JA, Cortez, V, Toor, H, et al. Moyamoya: An update and review. Cureus 2020; 12: e10994.
Google Scholar | Medline7. Lee, S, Rivkin, MJ, Kirton, A, et al. Moyamoya disease in children: Results from the international pediatric stroke study. J Child Neurol 2017; 32: 924–929.
Google Scholar | SAGE Journals | ISI8. Seol, HJ, Wang, KC, Kim, SK, et al. Headache in pediatric moyamoya disease: Review of 204 consecutive cases. J Neurosurg 2005; 103: 439–442.
Google Scholar | Medline | ISI9. Kraemer, M, Lee, SI, Ayzenberg, I, et al. Headache in Caucasian patients with Moyamoya angiopathy – a systematic cohort study. Cephalalgia 2017; 37: 496–500.
Google Scholar | SAGE Journals | ISI10. Battistella, PA, Carollo, C. Clinical and neuroradiological findings of moyamoya disease in Italy. Clin Neurol Neurosurg 1997; 99: S54–S57.
Google Scholar | Crossref | Medline | ISI11. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018; 38: 1–211.
Google Scholar12. Funaki, T, Takahashi, JC, Houkin, K, et al. Effect of choroidal collateral vessels on de novo hemorrhage in moyamoya disease: Analysis of nonhemorrhagic hemispheres in the Japan Adult Moyamoya Trial. J Neurosurg 2019; 132: 408–414.
Google Scholar | Crossref | Medline13. Zach, V, Bezov, D, Lipton, RB, et al. Headache associated with moyamoya disease: A case story and literature review. J Headache Pain 2010; 11: 79–82.
Google Scholar | Crossref | Medline | ISI14. Bernstein, AL. Hemiplegic migraine and moyamoya disease. Am J Dis Child 1993; 147: 718–719.
Google Scholar | Medline15. Roy, C, Chatterjee, N. Hemiplegic migraine: An atypical presentation of Moyamoya disease. Saudi J Anaesth 2014; 8: S123–S124.
Google Scholar | Crossref | Medline16. Siddiqui, BA, Jairam, V, Johnson, MH, et al. Headache and focal neurologic signs following exposure to spicy aroma as an initial presentation of moyamoya disease. Interdiscip Neurosurg: Adv Techs Case Manag 2014; 1: 81–83.
Google Scholar | Crossref17. Siddiqui, MR, Khan, SU, Hoque, MA, et al. Moyamoya disease presented as a case of hemiplegic migraine. BMJ Case Rep 2010; 2010: bcr0220102764. doi: 10.1136/bcr.02.2010.2764.
Google Scholar18. Park-Matsumoto, YC, , Shimizu J. Migraine with aura-like headache associated with moyamoya disease. Acta Neurol Scand 1999; 100: 119–121.
Google Scholar | Crossref | Medline19. Sewell, RA, Johnson, DJ, Fellows, DW. Cluster headache associated with moyamoya. J Headache Pain 2009; 10: 65–67.
Google Scholar | Crossref | Medline20. Kwon, OK. Headache and aneurysm. Neuroimaging Clin N Am 2019; 29: 255–260.
Google Scholar | Crossref | Medline21. Ray, BS, Wolff, HG. Experimental studies on headache: Pain-sensitive structures of the head and their significance in headache. Arch Surg 1940; 41: 813–856.
Google Scholar | Crossref22. Bedini, G, Blecharz, KG, Nava, S, et al. Vasculogenic and angiogenic pathways in moyamoya disease. Curr Med Chem 2016; 23: 315–345.
Google Scholar | Crossref | Medline | ISI23. Blecharz, KG, Frey, D, Schenkel, T, et al. Autocrine release of angiopoietin-2 mediates cerebrovascular disintegration in Moyamoya disease. J Cereb Blood Flow Metab 2017; 37: 1527–1539.
Google Scholar | SAGE Journals | ISI24. Fujimura, M, Tominaga, T. Diagnosis of moyamoya disease: International standard and regional differences. Neurol Med Chir (Tokyo) 2015; 55: 189–193.
Google Scholar | Crossref | Medline | ISI25. Khan, S, Amin, FM, Christensen, CE, et al. Meningeal contribution to migraine pain: A magnetic resonance angiography study. Brain 2019; 142: 93–102.
Google Scholar | Crossref | Medline26. Levy, D, Burstein, R, Kainz, V, et al. Mast cell degranulation activates a pain pathway underlying migraine headache. Pain 2007; 130: 166–176.
Google Scholar | Crossref | Medline | ISI27. Christensen, CE, Younis, S, Lindberg, U, et al. Intradural artery dilation during experimentally induced migraine attacks. Pain 2021; 162: 176–183.
Google Scholar | Crossref | Medline28. Kawabori, M, Kuroda, S, Nakayama, N, et al. Effective surgical revascularization improves cerebral hemodynamics and resolves headache in pediatric Moyamoya disease. World Neurosurg 2013; 80: 612–619.
Google Scholar | Crossref | Medline | ISI29. Bohara, M, Sugata, S, Nishimuta, Y, et al. Effect of revascularization on headache associated with moyamoya disease in pediatric patients. Hiroshima J Med Sci 2015; 64: 39–44.
Google Scholar | Medline30. Aihara, Y, Kashiwase, S, Chiba, K, et al. Aspirin use and platelet aggregation in ischemic onset-type pediatric moyamoya patients with intractable headaches (moya-ache). Childs Nerv Syst 2021; 37: 1649–1657.
Google Scholar | Crossref | Medline31. Acker, G, Fekonja, L, Vajkoczy, P. Surgical management of moyamoya disease. Stroke 2018; 49: 476–482.
Google Scholar | Crossref | Medline32. Patel, NN, Mangano, FT, Klimo, P Indirect revascularization techniques for treating moyamoya disease. Neurosurg Clin N Am 2010; 21: 553–563.
Google Scholar | Crossref | Medline33. Aydin, K, Okuyaz, C, Gucuyener, K, et al. Moyamoya disease presented with migrainelike headache in a 4-year-old girl. J Child Neurol 2003; 18: 361–363.
Google Scholar | SAGE Journals | ISI34. Vuignier, S, Akioka, N, Hamada, H, et al. Headache attack followed by rapid disease progression in pediatric moyamoya disease – how should we manage it? Childs Nerv Syst 2014; 30: 1733–1736.
Google Scholar | Crossref | Medline35. Tozzi, E, Antenucci, A, Di Loreto, S, et al. Moyamoya disease and headache: Case report. J Headache Pain 2015; 16: A73.
Google Scholar | Crossref | Medline36. Matsushima, Y, Aoyagi, M, Koumo, Y, et al. Effects of encephalo-duro-arterio-synangiosis on childhood moyamoya patients – swift disappearance of ischemic attacks and maintenance of mental capacity. Neurol Med Chir (Tokyo) 1991; 31: 708–714.
Google Scholar | Crossref | Medline37. Kim, SK, Cho, BK, Phi, JH, et al. Pediatric moyamoya disease: An analysis of 410 consecutive cases. Ann Neurol 2010; 68: 92–101.
Google Scholar | Crossref | Medline | ISI38. Matsushima, Y, Aoyagi, M, Niimi, Y, et al. Symptoms and their pattern of progression in childhood moyamoya disease. Brain Dev 1990; 12: 784–789.
Google Scholar | Crossref | Medline | ISI39. Liu, X-F, Jung, DK. Moyamoya disease and migraine like headaches. Schweiz Arch Neurol Psychiatr 1999; 15: 272–274.
Google Scholar40. Okada, Y, Kawamata, T, Kawashima, A, et al. The efficacy of superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease complaining of severe headache. J Neurosurg 2012; 116: 672–679.
Google Scholar | Crossref | Medline41. Diaz, UJ, Caban-Martinez, AJ, Halder, GE. Presentation with recurrent intractable headache: A patient with moyamoya syndrome – case report. Neurol Med Chir (Tokyo) 2014; 54: 133–135.
Google Scholar | Crossref | Medline42. Azzam, DB, Sharma, AN, Tiourin, E, et al. A case report of moyamoya disease presenting as headache in a 35-year-old Hispanic man. Cureus 2019; 11: e4426.
Google Scholar | Medline43. Gao, B, Kang, K, Zhang, J, et al. Clinical characteristics and long-term outcome of headaches associated with moyamoya disease in the Chinese population – a cohort study. Front Neurol 2020; 11: 605636.
Google Scholar | Crossref | Medline44. Katano, H, Nishikawa, Y, Yamada, H, et al. Association of superficial temporal artery dilatation with headache after revascularization in adult moyamoya disease. World Neurosurg 2019; 129: e594–e606.
Google Scholar | Crossref | Medline45. Scott, RM, Smith, JL, Robertson, RL, et al. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg 2004; 100: 142–149.
Google Scholar | Medline | ISI46. Shirane, R, Fujimura, M. Headache in moyamoya disease. In: Cho BK and Tominaga T (eds) Moyamoya disease update, 1st edn. Tokyo: Springer Japan, 2010, pp.101–104.
Google Scholar47. de Gray, LC, Matta, BF. Acute and chronic pain following craniotomy: A review. Anaesthesia 2005; 60: 693–704.
Google Scholar | Crossref | Medline | ISI48. Gunduz, A, Goksan, B, Kocer, N, et al. Headache in carotid artery stenting and angiography. Headache 2012; 52: 544–549.
Google Scholar | Crossref | Medline | ISI49. Biglione, B, Gitin, A, Gorelick, PB, et al. Aspirin in the treatment and prevention of migraine headaches: Possible additional clinical options for primary healthcare providers. Am J Med 2020; 133: 412–416.
Google Scholar | Crossref | Medline50. Diener, HC, Hartung, E, Chrubasik, J, et al. A comparative study of oral acetylsalicyclic acid and metoprolol for the prophylactic treatment of migraine. A randomized, controlled, double-blind, parallel group phase III study. Cephalalgia 2001; 21: 120–128.
Google Scholar | SAGE Journals | ISI51. Turk, WE, Uiterwijk, A, Pasmans, R, et al. Aspirin prophylaxis for migraine with aura: An observational case series. Eur Neurol 2017; 78: 287–289.
Google Scholar | Crossref | Medline52. Chambers, JB, Seed, PT, Ridsdale, L. Clopidogrel as prophylactic treatment for migraine: A pilot randomised, controlled study. Cephalalgia 2014; 34: 1163–1168.
Google Scholar | SAGE Journals |